All In Biotech

Free tool

FAERS Monitor: Clotic

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 217628 or its brand name (Clotic, Clotrimazole). Reports on generic versions are filed under their own applications.

Reports

11,719

Serious

9,076

77% of reports

Hospitalization

4,025

Death reported

937

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,384
  • nausea825
  • macular degeneration812
  • pain782
  • off label use769
  • headache754
  • dyspnoea726
  • fatigue660
  • diarrhoea618
  • pyrexia528
  • malaise483
  • rash478
  • anxiety470
  • weight decreased465
  • condition aggravated445

Reports by year received

View as table
YearReports
200484
2005114
2006135
2007113
2008122
2009149
2010169
2011229
2012342
2013215
2014296
2015452
2016629
2017588
2018786
2019961
2020863
2021993
2022931
2023893
20241,008
20251,037
2026609

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,440 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
macular degenerationSignal812130.8122.197,448
weight decreasedSignal4653.02.7622
anxietySignal4703.02.7618
pyrexiaSignal5282.72.5591
condition aggravatedSignal4452.62.4454
dyspnoeaSignal7262.32.1548
painSignal7822.32.1581
headacheSignal7542.22.0482
malaise4832.01.8237
rash4782.01.8232
drug ineffective1,3841.91.8613
nausea8251.91.8347
diarrhoea6181.71.6191
off label use7691.61.5169
fatigue6601.51.4122

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.